Trébucq A - Search Results

1

Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin.

Gninafon M, Tawo L, Kassa F, Monteiro GP, Zellweger JP, Shang H, Lambregts K, Trébucq A. Gninafon M, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2004 Oct;8(10):1242-7. Int J Tuberc Lung Dis. 2004. PMID: 15527157

2

The burden and outcomes of childhood tuberculosis in Cotonou, Benin.

Ade S, Harries AD, Trébucq A, Hinderaker SG, Ade G, Agodokpessi G, Affolabi D, Koumakpaï S, Anagonou S, Gninafon M. Ade S, et al. Among authors: trebucq a. Public Health Action. 2013 Mar 21;3(1):15-9. doi: 10.5588/pha.12.0055. Public Health Action. 2013. PMID: 26392989 Free PMC article.

3

MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin.

Ade S, Trébucq A, Harries AD, Affolabi D, Ade G, Agodokpessi G, Wachinou P, Anagonou S, Gninafon M. Ade S, et al. Among authors: trebucq a. Public Health Action. 2013 Jun 21;3(2):160-5. doi: 10.5588/pha.12.0101. Public Health Action. 2013. PMID: 26393021 Free PMC article.

4

A survey of TB services in hospitals in seven large cities in Asia and North Africa.

Chiang CY, Trébucq A, Billo N, Khortwong P, Elmoghazy E, Begum V, Aditama TY, Ansari A, Baral SC, Vianzon RG. Chiang CY, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2007 Jul;11(7):739-46. Int J Tuberc Lung Dis. 2007. PMID: 17609048

5

Tuberculosis treatment: dangerous regimens?

Rieder HL, Arnadottir T, Trébucq A, Enarson DA. Rieder HL, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2001 Jan;5(1):1-3. Int J Tuberc Lung Dis. 2001. PMID: 11263509 No abstract available.

6

In reply.

Koura KG, Trébucq A, Schwoebel V. Koura KG, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2017 Apr 1;21(4):475-476. doi: 10.5588/ijtld.17.0025-4. Int J Tuberc Lung Dis. 2017. PMID: 28284271 No abstract available.

7

In reply to 'Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact' [Correspondence].

Trébucq A, Harries AD. Trébucq A, et al. Int J Tuberc Lung Dis. 2012 May 1;16(5):702. doi: 10.5588/ijtld.12.0131-2. Int J Tuberc Lung Dis. 2012. PMID: 29070250 No abstract available.

8

Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.

Harries AD, Schwoebel V, Monedero-Recuero I, Aung TK, Chadha S, Chiang CY, Conradie F, Dongo JP, Heldal E, Jensen P, Nyengele JPK, Koura KG, Kumar AMV, Lin Y, Mlilo N, Nakanwagi-Mukwaya A, Ncube RT, Nyinoburyo R, Oo NL, Patel LN, Piubello A, Rusen ID, Sanda T, Satyanarayana S, Syed I, Thu AS, Tonsing J, Trébucq A, Zamora V, Zishiri C, Hinderaker SG, Aït-Khaled N, Roggi A, Caminero Luna J, Graham SM, Dlodlo RA, Fujiwara PI. Harries AD, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2019 Feb 1;23(2):241-251. doi: 10.5588/ijtld.18.0207. Int J Tuberc Lung Dis. 2019. PMID: 30808459

9

QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment.

Monedero-Recuero I, Hernando-Marrupe L, Sánchez-Montalvá A, Cox V, Tommasi M, Furin J, Chiang CY, Quelapio M, Koura KG, Trébucq A, Padanilam X, Dravniece G, Piubello A. Monedero-Recuero I, et al. Among authors: trebucq a. Int J Tuberc Lung Dis. 2018 Oct 26. doi: 10.5588/ijtld.18.0423. Online ahead of print. Int J Tuberc Lung Dis. 2018. PMID: 30366516

10

In reply to 'Should Xpert® MTB/RIF be rolled out in low-income countries?' [Correspondence].

Trébucq A, Harries AD, Rieder HL. Trébucq A, et al. Int J Tuberc Lung Dis. 2012 May 1;16(5):703-704. doi: 10.5588/ijtld.12.0034-2. Int J Tuberc Lung Dis. 2012. PMID: 29070251 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results